[1]
|
Han, D, ó Hartaigh, B., Lee, J.H., et al. (2016) Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism. PLOS ONE, 11, e0153514.
https://doi.org/10.1371/journal.pone.0153514
|
[2]
|
Fei, X., Wang, H., Yuan, W., Wo, M. and Jiang, L. (2017) Tis-sue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metas-tasis in Patients with Lung Cancer. BioMed Research International, 2017, Article ID: 8983763. https://doi.org/10.1155/2017/8983763
|
[3]
|
Goldhaber, S.Z. and Bounameaux, H. (2012) Pulmonary Embolism and Deep Vein Thrombosis. The Lancet, 379, 1835-1846. https://doi.org/10.1016/S0140-6736(11)61904-1
|
[4]
|
Heit, J.A. (2005) Cancer and Venous Thromboembolism: Scope of the Problem. Cancer Control, 12, 5-10.
https://doi.org/10.1177/1073274805012003S02
|
[5]
|
Beer, J.H., Haeberli, A., Vogt, A., et al. (2002) Coagulation Markers Predict Survival in Cancer Patients. Journal of Thrombosis and Haemostasis, 88, 745-749. https://doi.org/10.1055/s-0037-1613296
|
[6]
|
Gieseler, F., Lühr, I., Kunze, T., et al. (2007) Activated Coagulation Factors in Human Malignant Effusions and Their Contribution to Cancer Cell Metastasis and Therapy. Journal of Thrombosis and Haemostasis, 97, 1023-1030.
https://doi.org/10.1160/TH06-12-0712
|
[7]
|
Gil-Bernabé, A.M., Ferjančič, Š., Tlalka, M., et al. (2012) Recruitment of Monocytes/Macrophages by Tissue Factor-Mediated Coagulation Is Essential for Metastatic Cell Survival and Premetastatic Niche Establishment in Mice. Blood, 119, 3164-3175. https://doi.org/10.1182/blood-2011-08-376426
|
[8]
|
Zhang, W.-W., Liu, K.-J., Hu, G.-L. and Liang, W.-J. (2015) Preoperative Platelet/Lymphocyte Ratio Is a Superior Prognostic Factor Compared to Other Systemic Inflammatory Re-sponse Markers in Ovarian Cancer Patients. Tumor Biology, 36. 8831-8837. https://doi.org/10.1007/s13277-015-3533-9
|
[9]
|
Watrowski, R. and Zeillinger, R. (2016) Simple Laboratory Score Improves the Preoperative Diagnosis of Adnexal Mass. Tumor Biology, 37, 4343-4349. https://doi.org/10.1007/s13277-015-4280-7
|
[10]
|
Narod, S. (2016) Can Advanced-Stage Ovarian Cancer Be Cured? Nature Reviews Clinical Oncology, 13, 255-261.
https://doi.org/10.1038/nrclinonc.2015.224
|
[11]
|
Wei, S.U., Li, H. and Zhang, B. (2016) The Diagnostic Value of Serum HE4 and CA-125 and ROMA Index in Ovarian Cancer. Biomedical Reports, 5, 41-44. https://doi.org/10.3892/br.2016.682
|
[12]
|
Ogata, Y., Heppelmann, C.J., Charlesworth, M.C., et al. (2006) Elevated Levels of Phosphorylated Fibrinogen-α-Isoforms and Differential Expression of Other Post-Translationally Modified Proteins in the Plasma of Ovarian Cancer Patients. Journal of Proteome Research, 5, 3318-3325. https://doi.org/10.1021/pr060344+
|
[13]
|
Miralles, C., Orea, M., España, P., et al. (2003) Cancer Antigen 125 As-sociated with Multiple Benign and Malignant Athologies. Annals of Surgical Oncology, 10, 150-154. https://doi.org/10.1245/ASO.2003.05.015
|
[14]
|
Shiau, C.-S., Chang, M.-Y., Chiang, C.-H., et al. (2003) Ovarian Endometrioma Associated with very High Serum CA-125 Levels. Chang Gung Medical Journal, 26, 695-699.
|
[15]
|
Tiwari, R.K., Saha, K., Mukhopadhyay, D., et al. (2016) Evaluation of Preoperative Serum Levels of CA 125 and Expression of p53 in Ovarian Neoplasms: A Prospective Clinicopathological Study in a Tertiary Care Hospital. The Journal of Obstetrics and Gynecology of India, 66, 107-114. https://doi.org/10.1007/s13224-014-0611-7
|
[16]
|
Gadducci, A., Cosio, S., Tana, R. and Genazzani, A.R. (2009) Serum and Tissue Biomarkers as Predictive and Prognostic Variables in Epithelial Ovarian Cancer. Critical Reviews in Oncology/Hematology, 69, 12-27.
https://doi.org/10.1016/j.critrevonc.2008.05.001
|
[17]
|
Zhang, Y.L., Chen, J.H., Lu, W., et al. (2016) Efficacy of Postoperative Hormone Replacement Therapy on Prognosis of Patients with Serous ovarian Carcinoma. Chinese Medical Journal, 129, 1316-1321.
https://doi.org/10.4103/0366-6999.182835
|
[18]
|
Diaz-Gil, D., Fintelmann, F.J., Molaei, S., et al. (2016) Prediction of 5-Year Survival in Advanced-Stage Ovarian Cancer Patients Based on Computed Tomography Peritoneal Carcinoma-tosis Index. Abdominal Radiology, 41, 2196-202. https://doi.org/10.1007/s00261-016-0817-5
|
[19]
|
Gupta, G.P. and Massague, J. (2006) Cancer Metastasis: Building a Framework. Cell, 127, 679-695.
https://doi.org/10.1016/j.cell.2006.11.001
|
[20]
|
Im, J.H., Fu, W., Wang, H., Bhatia, S.K., Hammer, D.A., Kowalska, M.A., et al. (2004) Coagulation Facilitates Tumor Cell Spreading in the Pulmonary Vasculature during Early Metastatic Colony Formation. Cancer Research, 64, 8613-8619. https://doi.org/10.1158/0008-5472.CAN-04-2078
|
[21]
|
Gay, L.J. and Felding-Habermann, B. (2011) Contribution of Platelets to Tumour Metastasis. Nature Reviews Cancer, 11, 123-134. https://doi.org/10.1038/nrc3004
|
[22]
|
Palumbo, J.S., Talmage, K.E., Massari, J.V., La Jeunesse, C.M., Flick, M.J., Kombrinck, K.W., et al. (2005) Platelets and Fibrin(ogen) Increase Metastatic Potential by Impeding Natural Killer Cell-Mediated Elimination of Tumor Cells. Blood, 105, 178-185. https://doi.org/10.1182/blood-2004-06-2272
|
[23]
|
Biggerstaff, J.P., Weidow, B., Vidosh, J., Dexheimer, J., Patel, S. and Patel, P. (2006) Soluble Fibrin Inhibits Monocyte Adherence and Cytotoxicity against Tumor Cells: Implications for Cancer Metastasis. Thrombosis Journal, 4, Article No. 12. https://doi.org/10.1186/1477-9560-4-12
|
[24]
|
Righini, M., Perrier, A., De Moerloose, P. and Bounameaux, H. (2008) D-Dimer for Venous Thromboembolism Diagnosis: 20 Years Later. Journal of Thrombosis and Haemostasis, 6, 1059-1071.
https://doi.org/10.1111/j.1538-7836.2008.02981.x
|
[25]
|
Ay, C., Vormittag, R., Dunkler, D., Simanek, R., Chiriac, A.L., Drach, J., et al. (2009) D-Dimer and Prothrombin Fragment 1+2 Predict Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study. Journal of Clinical Oncology, 27, 4124-4129. https://doi.org/10.1200/JCO.2008.21.7752
|
[26]
|
Dompmartin, A., Ballieux, F., Thibon, P., Lequerrec, A., Hermans, C., Clapuyt, P., et al. (2009) Elevated D-Dimer Level in the Differential Diagnosis of Venous Malformations. Archives of Dermatology, 145, 1239-1244.
https://doi.org/10.1001/archdermatol.2009.296
|
[27]
|
Go, S.I., Lee, M.J., Lee, W.S., Choi, H.J., Lee, U.S., Kim, R.B., et al. (2015) D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by Chemotherapy. Medicine, 94, e951.
https://doi.org/10.1097/MD.0000000000000951
|
[28]
|
Tomimaru, Y., Yano, M., Takachi, K., Kishi, K., Miyashiro, I., Ohue, M., et al. (2006) Plasma D-Dimer Levels Show Correlation with Number of Lymph Node Metastases in Pa-tients with Esophageal Cancer. Journal of the American College of Surgeons, 202, 139-145. https://doi.org/10.1016/j.jamcollsurg.2005.08.008
|
[29]
|
Lippi, G., Franchini, M., Biasiutti, C., Dellagiacoma, G., Salvagno, G.L. and Guidi, G.C. (2007) Increased D-Dimer Value and Occult Cancer in the Absence of Detectable Thrombosis. Haematologica, 92, 53-55.
https://doi.org/10.3324/haematol.12237
|
[30]
|
Ay, C., Dunkler, D., Pirker, R., Thaler, J., Quehenberger, P., Wagner, O., et al. (2012) High D-Dimer Levels Are Associated with Poor Prognosis in Cancer Patients. Haematologica, 97, 1158-1164.
https://doi.org/10.3324/haematol.2011.054718
|
[31]
|
Stender, M.T., Larsen, T.B., Sorensen, H.T. and Thor-lacius-Ussing, O. (2012) Preoperative Plasma D-Dimer Predicts 1-Year Survival in Colorectal Cancer Patients with Ab-sence of Venous Thromboembolism (VTE): A Prospective Clinical Cohort Study. Journal of Thrombosis and Haemo-stasis, 10, 2027-2031.
https://doi.org/10.1111/j.1538-7836.2012.04887.x
|
[32]
|
Tas, F., Ciftci, R., Kilic, L., Bilgin, E., Keskin, S., Sen, F., et al. (2012) Clinical and Prognostic Significance of Coagulation Assays in Melanoma. Melanoma Research, 22, 368-375. https://doi.org/10.1097/CMR.0b013e328357be7c
|
[33]
|
Diao, D., Zhu, K., Wang, Z., Cheng, Y., Li, K., Pei, L., et al. (2013) Prognostic Value of the D-Dimer Test in Oesophageal Cancer during the Perioperative Period. The Journal of Surgical Oncology, 108, 34-41.
https://doi.org/10.1002/jso.23339
|
[34]
|
Diao, D., Wang, Z., Cheng, Y., Zhang, H., Guo, Q., Song, Y., Zhu, K., Li, K., Liu, D. and Dang, C. (2014) D-Dimer: Not Just an Indicator of Venous Thrombosis but a Predictor of Asymptomatic Hematogenous Metastasis in Gastric Cancer Patients. PLOS ONE, 9, e101125. https://doi.org/10.1371/journal.pone.0101125
|
[35]
|
Zhou, Y.X., Yang, Z.M., Feng, J., Shan, Y.-J., Wang, W.-L. and Mei, Y.-Q. (2013) High Plasma D-Dimer Level Is Associated with Decreased Survival in Patients with Lung Cancer. Tumor Biology, 34, 3701-3704.
https://doi.org/10.1007/s13277-013-0953-2
|
[36]
|
Li, W., Tang, Y., Song, Y., et al. (2018) Prognostic Role of Pre-treatment Plasma D-Dimer in Patients with Solid Tumors: A Systematic Review and Meta-Analysis. Cellular Physiology and Biochemistry, 45, 1663-1676.
https://doi.org/10.1159/000487734
|
[37]
|
Ma, X., Li, Y., Zhang, J., Huang, J. and Liu, L. (2014) Prognostic Role of D-Dimer in Patients with Lung Cancer: A Meta-Analysis. Tumor Biology, 35, 2103-2109. https://doi.org/10.1007/s13277-013-1279-9
|
[38]
|
Zhang, P.P., Sun, J.W., Wang, X.Y., Liu, X.M. and Li, K. (2013) Preoperative Plasma D-Dimer Levels Predict Survival in Patients with Operable Non-Small Cell Lung Cancer Inde-pendently of Venous Thromboembolism. European Journal of Surgical Oncology, 39, 951-956. https://doi.org/10.1016/j.ejso.2013.06.008
|
[39]
|
Jiang, H.G., Li, J., Shi, S.B., Chen, P., Ge, L.-P., Jiang, Q. and Tang, X.-P. (2014) Value of Fibrinogen and D-Dimer in Predicting Recurrence and Metastasis after Radical Surgery for Non-Small Cell Lung Cancer. Medical Oncology, 31, Article No. 22. https://doi.org/10.1007/s12032-014-0022-8
|
[40]
|
Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. and Forma, D. (2011) Global Cancer Statistics. CA, 61, 69-90.
https://doi.org/10.3322/caac.20107
|
[41]
|
Torre, L.A., Siegel, R.L. and Jemal, A. (2016) Lung Cancer Statistics. In: Ahmad, A. and Gadgeel, S., Eds., Lung Cancer and Personalized Medicine, Advances in Experimental Medicine and Bi-ology, Vol. 893, Springer, Cham, 1-19.
https://doi.org/10.1007/978-3-319-24223-1_1
|